Literature DB >> 21113769

Physical activity and hematological cancer survivorship.

Claudio L Battaglini1.   

Abstract

As previously presented in other chapters of this book, exercise has been shown through large scale studies to be associated with significant improvements in physical and psychological parameters in patients with one of several different tumor types (Galvao et al. 2010; Schwartz and Winters-Stone 2009; Galvao et al. 2009; Segal et al. 2009; Courneya et al. 2008a, b; Ligibel et al. 2008; Courneya et al. 2007; Schmitz et al. 2005a; Fairey et al. 2005). In addition, well conducted systematic reviews of the literature that have explored the effects of exercise before, during, or after anticancer therapy have consistently shown positive outcomes to patients treated for solid tumors. Consistent findings include an overall reduction in fatigue, depression, anxiety, and distress, paired with positive changes in fitness parameters such as aerobic capacity and overall muscle function (Speck et al. 2010; Jones et al. 2006; McNeely et al. 2006; Markes et al. 2006; Schmitz et al. 2005; Galvao and Newton 2005). However, a relative paucity of data exists in the area of exercise interventions for adult patients with hematological malignancies. This chapter reviews the current literature regarding the administration of exercise in adult patients diagnosed with hematological cancer. The few exercise intervention studies conducted in patients with hematological cancers suggest that it is feasible to administer exercise to most patients and that exercise should be considered as an intervention to alleviate treatment-related symptoms. Yet, efficacy along with the appropriate mode, intensity, and frequency of exercise training in different types of hematological cancers are yet to be established and require further research.

Entities:  

Mesh:

Year:  2011        PMID: 21113769     DOI: 10.1007/978-3-642-04231-7_12

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  7 in total

Review 1.  Psychosocial care in cancer.

Authors:  Samantha B Artherholt; Jesse R Fann
Journal:  Curr Psychiatry Rep       Date:  2012-02       Impact factor: 5.285

2.  Perceived Benefits and Barriers to Exercise for Recently Treated Adults With Acute Leukemia

Authors:  Ashley Leak Bryant; AnnMarie L Walton; Mackenzi Pergolotti; Brett Phillips; Charlotte Bailey; Deborah K Mayer; Claudio Battaglini
Journal:  Oncol Nurs Forum       Date:  2017-07-01       Impact factor: 2.172

3.  Physical activity participation and barriers for people with multiple myeloma.

Authors:  Melinda Craike; Kaye Hose; Patricia M Livingston
Journal:  Support Care Cancer       Date:  2012-10-02       Impact factor: 3.603

4.  Comparison of Methods for Determining Aerobic Exercise Intensity Using Heart Rate in Acute Leukemia Patients Prior to Induction Chemotherapy.

Authors:  Christina Story; Ashley Leak Bryant; Brett Phillips; Charlotte Bailey; Edgar W Shields; Claudio Battaglini
Journal:  Biol Res Nurs       Date:  2016-03-01       Impact factor: 2.522

5.  The Effects of Exercise on Patient-Reported Outcomes and Performance-Based Physical Function in Adults With Acute Leukemia Undergoing Induction Therapy: Exercise and Quality of Life in Acute Leukemia (EQUAL).

Authors:  Ashley Leak Bryant; Allison M Deal; Claudio L Battaglini; Brett Phillips; Mackenzi Pergolotti; Erin Coffman; Matthew C Foster; William A Wood; Charlotte Bailey; Anthony C Hackney; Deborah K Mayer; Hyman B Muss; Bryce B Reeve
Journal:  Integr Cancer Ther       Date:  2017-03-24       Impact factor: 3.279

6.  Patient Activation through Counseling and Exercise--Acute Leukemia (PACE-AL)--a randomized controlled trial.

Authors:  Mary Jarden; Tom Møller; Lars Kjeldsen; Henrik Birgens; Jesper Frank Christensen; Karl Bang Christensen; Finn Diderichsen; Carsten Hendriksen; Lis Adamsen
Journal:  BMC Cancer       Date:  2013-10-02       Impact factor: 4.430

7.  Sleep problems and their interaction with physical activity and fatigue in hematological cancer patients during onset of high dose chemotherapy.

Authors:  Lucia Castelli; Thomas Elter; Florian Wolf; Matthew Watson; Alexander Schenk; Karen Steindorf; Wilhelm Bloch; Michael Hallek; Niklas Joisten; Philipp Zimmer
Journal:  Support Care Cancer       Date:  2021-07-10       Impact factor: 3.603

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.